Cargando…

Automated Analysis of Diffusion‐Weighted Magnetic Resonance Imaging for the Differential Diagnosis of Multiple System Atrophy from Parkinson's Disease

BACKGROUND: Manual region‐of‐interest analysis of putaminal and middle cerebellar peduncle diffusivity distinguishes patients with multiple system atrophy (MSA) and Parkinson's disease (PD) with high diagnostic accuracy. However, a recent meta‐analysis found substantial between‐study heterogene...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krismer, Florian, Beliveau, Vincent, Seppi, Klaus, Mueller, Christoph, Goebel, Georg, Gizewski, Elke R., Wenning, Gregor K., Poewe, Werner, Scherfler, Christoph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2020
Materias:	Regular Issue Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7891649/ https://www.ncbi.nlm.nih.gov/pubmed/32935402 http://dx.doi.org/10.1002/mds.28281

Ejemplares similares

Morphometric MRI profiles of multiple system atrophy variants and implications for differential diagnosis
por: Krismer, Florian, et al.
Publicado: (2019)

Dorsolateral Nigral Hyperintensity on 1.5 T Versus 3 T Susceptibility‐Weighted Magnetic Resonance Imaging in Neurodegenerative Parkinsonism
por: Grossauer, Anna, et al.
Publicado: (2023)

Sensitivity to Change and Patient‐Centricity of the Unified Multiple System Atrophy Rating Scale Items: A Data‐Driven Analysis
por: Krismer, Florian, et al.
Publicado: (2022)

Disease Progression in Multiple System Atrophy—Novel Modeling Framework and Predictive Factors
por: Kühnel, Line, et al.
Publicado: (2022)

Diffusion-weighted MRI distinguishes Parkinson disease from the parkinsonian variant of multiple system atrophy: A systematic review and meta-analysis
por: Bajaj, Sweta, et al.
Publicado: (2017)

Orthostatic Hypotension in Parkinson's Disease: Do Height and Weight Matter?
por: Campese, Nicole, et al.
Publicado: (2021)

Cardiac sympathetic innervation in Parkinson’s disease versus multiple system atrophy
por: Eckhardt, Christine, et al.
Publicado: (2022)

Development and Validation of Automated Magnetic Resonance Parkinsonism Index 2.0 to Distinguish Progressive Supranuclear Palsy‐Parkinsonism From Parkinson's Disease
por: Quattrone, Andrea, et al.
Publicado: (2022)

Revisiting brain iron deficiency in restless legs syndrome using magnetic resonance imaging
por: Beliveau, Vincent, et al.
Publicado: (2022)

Potential of Diffusion Tensor Imaging and Relaxometry for the Detection of Specific Pathological Alterations in Parkinson's Disease (PD)
por: Esterhammer, Regina, et al.
Publicado: (2015)

Automated segmentation of deep brain nuclei using convolutional neural networks and susceptibility weighted imaging
por: Beliveau, Vincent, et al.
Publicado: (2021)

Disease-Modifying Therapies for Multiple System Atrophy: Where Are We in 2022?
por: Sidoroff, Victoria, et al.
Publicado: (2022)

Multiple system atrophy as emerging template for accelerated drug discovery in α-synucleinopathies
por: Krismer, Florian, et al.
Publicado: (2014)

The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy
por: Wenning, Gregor K., et al.
Publicado: (2022)

Intact Olfaction in a Mouse Model of Multiple System Atrophy
por: Krismer, Florian, et al.
Publicado: (2013)

HFP‐QSMGAN: QSM from homodyne‐filtered phase images
por: Beliveau, Vincent, et al.
Publicado: (2022)

Cognition in multiple system atrophy: a single‐center cohort study
por: Eschlböck, Sabine, et al.
Publicado: (2020)

Application of the Updated Movement Disorder Society Criteria for Prodromal Parkinson's Disease to a Population‐Based 10‐Year Study
por: Marini, Kathrin, et al.
Publicado: (2021)

Neuroprotection by Epigenetic Modulation in a Transgenic Model of Multiple System Atrophy
por: Sturm, Edith, et al.
Publicado: (2016)

Towards translational therapies for multiple system atrophy
por: Kuzdas-Wood, Daniela, et al.
Publicado: (2014)

Symptomatic hemiparkinsonism due to extensive middle and posterior fossa arachnoid cyst: case report
por: Wimmer, Bernadette, et al.
Publicado: (2020)

An antibody microarray analysis of serum cytokines in neurodegenerative Parkinsonian syndromes
por: Mahlknecht, Philipp, et al.
Publicado: (2012)

Application of a Simple Parkinson's Disease Risk Score in a Longitudinal Population‐Based Cohort
por: Marini, Kathrin, et al.
Publicado: (2020)

No effect of age, gender and total intracranial volume on brainstem MR planimetric measurements
por: Mangesius, Stephanie, et al.
Publicado: (2020)

Non‐Motor Symptoms in Parkinson's Disease are Reduced by Nabilone
por: Peball, Marina, et al.
Publicado: (2020)

Family History for Neurodegeneration in Multiple System Atrophy: Does it Indicate Susceptibility?
por: Leys, Fabian, et al.
Publicado: (2022)

Different assessment tools to detect sarcopenia in patients with Parkinson's disease
por: Valent, Dora, et al.
Publicado: (2022)

How Does Deep Brain Stimulation Change the Course of Parkinson's Disease?
por: Mahlknecht, Philipp, et al.
Publicado: (2022)

Characterization of gait variability in multiple system atrophy and Parkinson’s disease
por: Sidoroff, Victoria, et al.
Publicado: (2020)

The Concept of Prodromal Parkinson’s Disease
por: Mahlknecht, Philipp, et al.
Publicado: (2015)

Nomogram to Predict the Probability of Functional Dependence in Early Parkinson’s Disease
por: Valent, Dora, et al.
Publicado: (2023)

Urodynamic Evaluation in Multiple System Atrophy: A Retrospective Cohort Study
por: Eschlböck, Sabine, et al.
Publicado: (2021)

Sensor‐based gait analysis in atypical parkinsonian disorders
por: Raccagni, Cecilia, et al.
Publicado: (2018)

Impaired Inhibitory Control of Saccadic Eye Movements in Cervical Dystonia: An Eye‐Tracking Study
por: Carbone, Federico, et al.
Publicado: (2021)

Role and clinical utility of pramipexole extended release in the treatment of early Parkinson’s disease
por: Hametner, Eva-Maria, et al.
Publicado: (2012)

Prevalence and Burden of Gait Disorders in Elderly Men and Women Aged 60–97 Years: A Population-Based Study
por: Mahlknecht, Philipp, et al.
Publicado: (2013)

Apomorphine for Parkinson’s Disease: Efficacy and Safety of Current and New Formulations
por: Carbone, Federico, et al.
Publicado: (2019)

An update on the cerebellar subtype of multiple system atrophy
por: Ciolli, Ludovico, et al.
Publicado: (2014)

Effects of Nabilone on Sleep Outcomes in Patients with Parkinson's Disease: A Post‐hoc Analysis of NMS‐Nab Study
por: Peball, Marina, et al.
Publicado: (2022)

Prodromal Parkinson's disease: hype or hope for disease-modification trials?
por: Mahlknecht, Philipp, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mv17s08u8d8rqvl3v4gp75vpel